研發可攜式快速精準分子定點照護系統（Point of Care Testing），以第一線醫療診所、照護機構等為目標市場，在疫情期間早期掌握疫情，對年長高風險族群提供精準醫療降低重症，POCT減少後送集中檢測，解緩急重症醫療資源。新創公司規劃研發呼吸道疾病、黴漿菌肺、腸胃道感染、性傳染病、微生物抗藥性監測、腫瘤精準醫療以掌握市場成長商機。核心技術是磁奈米捕獲、光電整合晶片、常溫試劑、移動式加熱機構分子診斷機台。 Develop a portable, rapid and accurate molecular point-of-care testing system (Point of Care Testing), targeting front-line medical clinics, nursing institutions, etc., to grasp the epidemic early during the epidemic, and provide precision medicine to elderly and high-risk groups to reduce severe illness. POCT is reduced and sent for centralized testing to relieve emergency and severe medical resources. The new startup plans to develop respiratory diseases, Mycoplasma pneumonia, gastrointestinal infections, sexually transmitted diseases, microbial resistance monitoring, and precision cancer medicine to seize market growth opportunities. The core technology is magnetic nano capture, photoelectric integrated chip, room temperature reagent, mobile heating mechanism molecular diagnostic machine.